NSCLC: Immunotherapy Toxicity Management

Описание к видео NSCLC: Immunotherapy Toxicity Management

Paul K. Paik, MD, reviews the potential toxicities associated with checkpoint inhibitors in non–small cell lung cancer and provides an update on clinical trials investigating immunotherapy/chemotherapy combinations.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Комментарии

Информация по комментариям в разработке